United Therapeutics Corp (NASDAQ:UTHR)

183.69
Delayed Data
As of May 22
 +1.08 / +0.59%
Today’s Change
84.63
Today|||52-Week Range
190.29
+41.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line217.9M304.4M174.6M340.1M
 
 
 
 
 
Depreciation20.5M27.1M31.3M32.2M
 
 
 
 
 
Total Other Cash Flow41.6M64.0M331.8M183.4M
 
 
 
 
 
Funds From Operations361.4M531.8M641.9M740.8M
 
 
 
 
 
Funds From/For Other Operating Expenses111.3M208.2M216.7M385.6M
 
 
 
 
 
Net Cash Flow - Operating Activities250.2M323.6M425.3M355.3M
 
 
 
 
 
 
InvestingIncrease In Investments-815.7M-579.3M-793.0M-163.7M
 
 
 
 
 
Decrease In Investments733.9M527.9M529.9M549.6M
 
 
 
 
 
Capital Expenditures-36.0M-111.9M-31.9M-47.4M
 
 
 
 
 
Net Assets From Acquisitions -3.5M0.000.000.00
 
 
Other Investing - Uses-1.0K0.000.000.00
 
 
Net Cash Flow Investing-121.3M-163.4M-295.0M338.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings242.5M0.000.00140.0M
 
 
 
Long Term Debt Reduction-251.0M-999.0K-1.3M-317.8M
 
 
 
 
 
Net Proceeds Stock Sale24.4M16.8M29.3M53.5M
 
 
 
 
 
Common Preferred Redeemed0.00-188.0M-42.4M-483.1M
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing11.3M3.1M9.3M30.8M
 
 
 
 
 
Other Uses - Financing245.3M0.000.000.00
 
 
Net Cash Flow - Financing-218.1M-169.1M-5.1M-576.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-269.0K229.0K-319.0K-3.8M
 
 
 
 
 
 
Net Change In Cash-89.2M-8.9M125.2M117.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account